The scale of the gap

The numbers tell a sobering story. Malaysia consistently ranks among the top nations in Southeast Asia for research output, measured by the volume of academic publications and the number of patent applications filed by public universities and research institutions. Yet the proportion of that research output that is successfully commercialised, meaning translated into products, processes, or services that generate economic value, remains stubbornly low relative to comparable innovation economies.

Technology transfer offices exist in most of Malaysia’s major public universities, but many are under-resourced, understaffed, and lacking the commercial expertise needed to identify the most commercially promising innovations in their portfolios, protect them adequately through IP filings, and connect them with the industry partners who have the capability and the appetite to bring them to market. The result is a pipeline that leaks at every stage, from invention to protection to licensing to commercialisation.

Why commercialisation fails

Understanding why commercialisation fails in the Malaysian research context requires looking honestly at several structural issues that have proved resistant to incremental reform.

The first is the incentive structure within academic institutions. Malaysian academics are evaluated, promoted, and rewarded primarily on the basis of their publication record. Filing a patent, managing a technology transfer process, and negotiating a licensing agreement with an industry partner are time-consuming activities that generate little academic credit and no improvement in a researcher’s standing within the institution. Rational actors respond to incentives, and the incentives currently in place point firmly toward publication and away from commercialisation.

The second structural issue is the mismatch between academic IP ownership policies and commercial reality. In many Malaysian universities, IP ownership policies are either unclear, overly restrictive, or structured in ways that make licensing unattractive to potential industry partners. A company that is asked to license a technology on terms that give the university excessive control over downstream commercialisation decisions, or that impose unrealistic royalty structures on early-stage innovations with unproven commercial potential, will simply walk away. Flexibility, commercial realism, and a genuine willingness to share both the risk and the reward of commercialisation are prerequisites for successful technology transfer, and they are not universally present.

The third issue is the absence of a robust early-stage funding ecosystem for university spinouts and technology licensing ventures. In the United States and the United Kingdom, the university spinout model is supported by a well-developed ecosystem of seed funds, angel investors, technology-focused venture capital firms, and government co-investment programmes specifically designed to bridge the gap between academic proof of concept and commercial viability. In Malaysia, this ecosystem is thinner, and the funding options available to a researcher who wants to commercialise their innovation rather than simply license it are considerably more limited.

What a serious commercialisation initiative would look like

A genuine and effective commercialisation initiative for Malaysian research would need to address all three of these structural issues simultaneously rather than treating them as separate problems to be solved sequentially.

On incentives, the reform required is straightforward if politically difficult: academic promotion and performance evaluation criteria need to give meaningful weight to commercialisation outcomes alongside publication metrics. A researcher who successfully licenses a technology that generates revenue for their institution and creates jobs in the economy has created value that deserves recognition, and a system that fails to recognise it will continue to produce researchers who are rationally indifferent to commercialisation.

On IP ownership and licensing, universities need to review and modernise their policies with commercial reality as the primary reference point. This means adopting flexible licensing frameworks that can accommodate the full range of commercialisation models, from exclusive licences to spinout equity arrangements to royalty-bearing non-exclusive licences. It means establishing clear and transparent processes for evaluating and prioritising the commercialisation of research outputs. And it means investing in the commercial and legal expertise within technology transfer offices that is needed to negotiate deals that work for both the institution and the industry partner.

On funding, the government has a direct and important role to play. Targeted co-investment programmes that match private sector funding for university technology licensing and spinout ventures, grants specifically designed to support proof of concept development and prototype commercialisation, and tax incentives for companies that invest in commercialising Malaysian university research are all mechanisms that have been used successfully in other innovation economies and that deserve serious consideration here.

The role of IP strategy in commercialisation

One dimension of the commercialisation gap that deserves particular attention is the quality and strategic coherence of the IP protection that underpins research outputs. A technology that has been adequately protected through a well-drafted patent portfolio, with claims broad enough to provide meaningful exclusivity and coverage across the key commercial markets, is a significantly more attractive licensing prospect than one protected by a narrow, poorly drafted patent that a competitor can design around with minimal effort.

Many Malaysian university patents are filed primarily to meet institutional filing targets rather than as part of a coherent commercial strategy. The result is a portfolio that looks impressive in terms of numbers but that provides limited commercial value because the patents have not been drafted with licensing or enforcement in mind. Addressing this requires investment in professional patent drafting expertise and a shift in institutional culture from filing patents as an end in itself to protecting innovations as a means to a commercial end.

The cost of continued inaction

Every year that the commercialisation gap remains unaddressed represents a real and measurable economic cost. Innovations that could have generated revenue, created jobs, attracted foreign investment, and enhanced Malaysia’s reputation as a technology-driven economy instead sit in filing cabinets, expire unrenewed, or are quietly abandoned when their inventors move on. The cumulative cost of this waste, in terms of unrealised economic value, is difficult to quantify but almost certainly significant.

There is also a competitiveness cost. Malaysia’s regional peers, most notably Singapore but increasingly also Indonesia and Vietnam, are investing seriously in their innovation commercialisation infrastructure. A country that continues to produce strong research but fails to translate it into commercial outcomes will find itself falling behind in the competition for the high-value industries and the foreign direct investment that follows genuine innovation leadership.

Conclusion

The case for a serious, well-resourced, and structurally coherent commercialisation initiative for Malaysian research is not new. It has been made, in various forms, by academics, policymakers, and business leaders for years. What has been missing is not the diagnosis but the treatment: a sustained and honest commitment to addressing the incentive failures, the institutional rigidities, and the funding gaps that allow the commercialisation problem to persist.

Malaysia’s researchers are doing their part. The innovations are there. What remains overdue is the system that turns them into economic value.

For further enquiries or advice, please contact us at kass@kass.asia for expert guidance.